J. W. Box

Reorganization at Oryx Energy focuses on teamwork, technology

J. W. Box, 1993 .

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation.

J. W. Box, R. Califf, E. Topol, 2000, Journal of the American College of Cardiology.

Surgical control of clinically localized prostate carcinoma is equivalent in African‐American and White males

J. W. Box, C. Iselin, L. Layfield, 1998, Cancer.

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

J. W. Box, R. Califf, E. Topol, 2000 .

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.

J. W. Box, R. Califf, E. Topol, 2000, European heart journal.

Coordinated 2-halo-1,3,2-dioxaphosphorinane ligands. II: Syntheses and 13C, 31P and 95Mo NMR and IR spectroscopic characterization of some Cr and Mo pentacarbonyl complexes of 2-substituted-4-methyl-1,3,2-dioxaphosphorinanes

J. W. Box, J. Whitten, G. M. Gray, 1986 .

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

J. W. Box, J. Herndon, M. Green, 2001, Lung Cancer.